Insufficient scRNA-seq data for expression of RXFP2 at single-cell level.
Insufficient scRNA-seq data for expression of RXFP2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
adrenal gland | 85% | 42.92 | 219 / 258 | 0% | 0.01 | 1 / 230 |
thymus | 71% | 26.77 | 463 / 653 | 0% | 0.02 | 1 / 605 |
uterus | 65% | 86.68 | 110 / 170 | 1% | 0.03 | 5 / 459 |
breast | 52% | 26.37 | 237 / 459 | 0% | 0.01 | 2 / 1118 |
peripheral blood | 41% | 6.86 | 380 / 929 | 0% | 0 | 0 / 0 |
blood vessel | 37% | 7.37 | 492 / 1335 | 0% | 0 | 0 / 0 |
muscle | 34% | 4.84 | 273 / 803 | 0% | 0 | 0 / 0 |
adipose | 32% | 15.08 | 390 / 1204 | 0% | 0 | 0 / 0 |
skin | 31% | 6.25 | 556 / 1809 | 1% | 0.01 | 3 / 472 |
brain | 30% | 11.53 | 799 / 2642 | 0% | 0 | 0 / 705 |
lung | 26% | 2.45 | 149 / 578 | 1% | 0.02 | 13 / 1155 |
ovary | 22% | 65.88 | 39 / 180 | 0% | 0 | 0 / 430 |
kidney | 19% | 2.97 | 17 / 89 | 0% | 0.00 | 1 / 901 |
esophagus | 14% | 2.05 | 201 / 1445 | 1% | 0.02 | 2 / 183 |
spleen | 13% | 0.88 | 31 / 241 | 0% | 0 | 0 / 0 |
pancreas | 12% | 1.10 | 39 / 328 | 1% | 0.01 | 1 / 178 |
heart | 10% | 0.90 | 89 / 861 | 0% | 0 | 0 / 0 |
stomach | 2% | 0.16 | 8 / 359 | 2% | 0.05 | 5 / 286 |
prostate | 3% | 0.29 | 7 / 245 | 0% | 0.00 | 1 / 502 |
bladder | 0% | 0 | 0 / 21 | 2% | 0.26 | 11 / 504 |
intestine | 2% | 0.13 | 16 / 966 | 0% | 0.01 | 2 / 527 |
liver | 0% | 0.03 | 1 / 226 | 0% | 0 | 0 / 406 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0001556 | Biological process | oocyte maturation |
GO_0008584 | Biological process | male gonad development |
GO_0007190 | Biological process | activation of adenylate cyclase activity |
GO_0008285 | Biological process | negative regulation of cell population proliferation |
GO_0043066 | Biological process | negative regulation of apoptotic process |
GO_0007189 | Biological process | adenylate cyclase-activating G protein-coupled receptor signaling pathway |
GO_0007193 | Biological process | adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway |
GO_0043950 | Biological process | positive regulation of cAMP-mediated signaling |
GO_0009755 | Biological process | hormone-mediated signaling pathway |
GO_0005886 | Cellular component | plasma membrane |
GO_0016500 | Molecular function | protein-hormone receptor activity |
GO_0008528 | Molecular function | G protein-coupled peptide receptor activity |
GO_0017046 | Molecular function | peptide hormone binding |
Gene name | RXFP2 |
Protein name | Relaxin receptor 2 (G-protein coupled receptor 106) (G-protein coupled receptor affecting testicular descent) (Leucine-rich repeat-containing G-protein coupled receptor 8) (Relaxin family peptide receptor 2) |
Synonyms | LGR8 GREAT GPR106 |
Description | FUNCTION: Receptor for relaxin. The activity of this receptor is mediated by G proteins leading to stimulation of adenylate cyclase and an increase of cAMP. May also be a receptor for Leydig insulin-like peptide (INSL3). |
Accessions | Q8WXD0 ENST00000380314.2 [Q8WXD0-2] ENST00000298386.7 [Q8WXD0-1] |